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The generation of a population of memory 
cells providing long-term protective immunity 
is an important outcome of a primary T cell 
response and the goal of vaccination. Substan-
tial progress has been made in identifying the 
factors that contribute to the development and 
survival of CD8+ memory T cells, whereas 
less is known about CD4+ memory T cells. 
It has been postulated that brief stimulation of 
naive CD8+ T cells with antigen is suffi   cient 
to initiate the program leading to eff  ector and 
memory cell development (1, 2). Long-term 
persistence of the generated memory CD8+ T 
cells is independent of continued TCR stimu-
lation (3, 4) but depends on the presence of 
CD4+ helper T cells (5–9). Besides this newly 
emerging role of CD4+ T cells in CD8+ T cell 
memory maintenance, the cytokines IL-7 and 
IL-15, members of the common γ chain (γc) 
family, play an important role in the homeo-
stasis of CD8+ memory T cells (10–12). Just as 
for CD8+ T cells, survival of CD4+ memory T 
cells does not require continued contact with 
MHC molecules once the antigen has been 
cleared (13). However, the functional activity 
of the surviving memory cells seems to be posi-
tively infl  uenced by contact with MHC (14). 
Also, antigen dose and the maturation state of 
the APC during priming seem to infl  uence the 
subsequent capacity of T cells to acquire long-
term survival potential (15).
Studies using in vitro priming followed by 
adoptive transfer into immunocompetent re-
cipient mice have shown that proper eff  ector 
T cell diff  erentiation and exposure to IL-2 are 
required for the successful long-term survival 
of the primed CD4+ T cells in vivo (16, 17). 
However, there are very few studies addressing 
the problem of CD4+ memory T cell genera-
tion using in vivo priming systems. Moreover, 
most of these studies use lymphopenic animals, 
wherein the true requirements for memory cell 
survival may not surface because of the absence 
of competition with endogenous lymphocytes 
for survival factors (17). Thus, it has been pos-
tulated that γc family cytokines are not re-
quired for the generation and maintenance of 
CD4+ memory T cells in γc-defi  cient, lym-
phopenic mice (18). Recent evidence to the 
contrary suggests that IL-7 is an important sur-
vival factor for resting CD4+ memory T cells 
residing in an intact lymphoid compartment 
(19–21), whereas IL-2 contributes to the gen-
eration of memory cells during priming (17). 
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The common 𝗄 chain cytokines interleukin (IL)-2 and IL-7 are important regulators of 
T cell homeostasis. Although IL-2 is implicated in the acute phase of the T cell response, 
IL-7 is important for memory T cell survival. We asked whether regulated responsiveness to 
these growth factors is determined by temporal expression of the cytokine-specifi  c IL-2 
receptor (R) 𝗂 and IL-7R𝗂 chains. We demonstrate that IL-2R𝗂 is expressed early after 
priming in T cell receptor–transgenic CD4+ T cells, whereas IL-7R𝗂 expression is lost. In the 
later stage of the response, IL-7R𝗂 is reexpressed while IL-2R𝗂 expression is silenced. This 
reciprocal pattern of IL-2R𝗂/IL-7R𝗂 expression is disturbed when CD4+ T cells are primed 
in the absence of IL-2 signals. Primed IL-2−/− or CD25−/− (IL-2R𝗂−/−) CD4+ T cells, despite 
showing normal induction of activation markers and cell division, fail to reexpress IL-7R𝗂 
late in the response. Because the generation of CD4+ memory T cells is dependent on IL-7–
IL-7R𝗂 interactions, primed IL-2−/− or CD25−/− CD4+ T cells develop poorly into long-lived 
memory cells. Retrovirus-mediated expression of IL-7R𝗂 in IL-2−/− T cells restores their 
capacity for long-term survival. These results identify IL-2 as a factor regulating IL-7R𝗂 
expression and, consequently, memory T cell homeostasis in vivo.
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The phenotypes of mice defi  cient in IL-2, IL-7, or their re-
ceptors suggest an important role for these cytokines in the 
maintenance of T cell homeostasis (22). However, because 
both cytokines have a broad range of activities at diff  erent 
stages of T cell development, as well as on a variety of T cell 
subsets, it is diffi   cult to defi  ne their specifi  c roles in the gen-
eration of memory cells in intact, lymphocyte-suffi   cient ani-
mals. Because IL-2 and IL-7 share the γc for signaling, 
specifi  city of responsiveness and function will likely depend 
on temporally regulated expression of their unique, high af-
fi  nity α chain receptor component. The factors regulating 
expression of CD25 are fairly well described: TCR engage-
ment or IL-2 itself induces CD25 during T cell priming (23). 
However, the expression pattern and factors regulating 
IL-7Rα expression on mature CD4+ T cells are not well 
  defi  ned. Recent data from in vitro experiments suggest that 
IL-7 and IL-2 are negative regulators of IL-7Rα expression 
(24, 25). Given the importance of IL-7 signaling for the 
maintenance of naive and memory T cell populations, the 
mechanisms that control responsiveness to this cytokine in 
vivo are clearly crucial for understanding T cell homeostasis 
and memory.
In this study, we have followed IL-7Rα and IL-2Rα ex-
pression on CD4+ T cells during the priming and memory 
phases of an immune response. Using both in vitro and in 
vivo systems, we found that IL-2Rα and IL-7Rα show a re-
ciprocal expression pattern after priming. Surprisingly, early 
up-regulation of IL-2Rα, allowing IL-2 signaling, pro-
moted the generation of activated T cells reexpressing 
IL-7Rα. IL-7Rα reexpression correlated with the develop-
ment of a long-lived memory cell population, consistent with 
the function of IL-7 to promote long-term survival of CD4+ 
memory T cells (19–21). Thus, IL-2 and IL-7 serve unique 
functions in the generation of CD4+ memory T cells.
RESULTS
Reciprocal regulation of IL-2R𝗂 and IL-7R𝗂 expression 
during a T cell response
The ability of CD4+ T cells to respond eff  ectively to the cy-
tokines IL-2 and IL-7 depends on the expression of their 
high affi   nity IL-2Rα and IL-7Rα receptor chains on the cell 
surface. To follow expression of IL-2Rα and IL-7Rα during 
a CD4+ T cell response, naive OVA-specifi  c T cells from 
DO.11 TCR transgenic mice were primed with 1 μg/ml 
OVA peptide and APCs in vitro and analyzed for the pres-
ence of the receptors by antibody staining and fl  ow cytome-
try (Fig. 1 A). As expected, naive T cells were negative for 
IL-2Rα and expressed IL-7Rα. Antigen stimulation of 
DO.11 T cells led to a strong induction of IL-2Rα by day 2, 
whereas IL-7Rα was down-regulated in response to TCR 
triggering. By day 5, however, IL-7Rα expression was re-
stored on activated T cells, whereas IL-2Rα was diminishing 
(Fig. 1 A).
Because conditions of antigen presentation and cytokine 
exposure during in vitro priming of T cells do not necessarily 
mimic the in vivo situation, we developed a system to follow 
IL-2Rα and IL-7Rα on DO.11 T cells primed in vivo. 5 × 
106 naive, carboxyfl   uorescein diacetate succinimidyl ester 
(CFSE)–labeled DO.11 T cells were adoptively transferred 
into unmanipulated BALB/c recipients and primed the next 
day with 3 × 106 OVA-pulsed bone marrow–derived DCs. 
Spleens of the mice were harvested on days 1, 3, and 10 after 
priming, and DO.11 T cells were analyzed for the presence 
Figure 1.  Reciprocal regulation of IL-2R𝗂 and IL-7R𝗂 after T cell 
activation. (A) 2.5 × 105 CD4+ T cells from DO.11 mice were primed in 
vitro with 1 μg/ml OVA peptide and 2.5 × 106 APCs. Naive T cells and 
cells harvested from the cultures on days 2 and 5 of priming were stained 
with KJ1-26, anti-CD4, and antibodies against IL-2Rα and IL-7Rα. Recep-
tor expression levels were analyzed by fl  ow cytometry. Data are represen-
tative of two independent experiments. (B) 5 × 106 naive DO.11 T cells 
were adoptively transferred into BALB/c mice and primed in vivo 24 h 
later with 3 × 106 OVA-pulsed DCs. Histograms show expression of 
CD62L and CD44 on naive and primed (day 3) KJ1-26+CD4+ T cells in the 
spleen. (C) CFSE-labeled DO.11 T cells were primed as in B (left) or with 
control DCs (no OVA; right). On day 3 after priming, spleen cell suspen-
sions were stained with KJ1-26 and anti-CD4. Dot plots show CFSE dilu-
tion versus KJ1-26 staining gated on the CD4+ T cell population. Numbers 
indicate percentages of KJ1-26+ and KJ1-26− T cells within the total 
CD4+ T cell population. (D) Spleens of the primed mice from B were 
harvested on the indicated days, and IL-2Rα and IL-7Rα expression on 
KJ1-26+CD4+ T cells was determined as in A. Data are representative of 
three separate experiments.JEM VOL. 204, March 19, 2007  549
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of IL-2Rα and IL-7Rα. To ensure that the DO.11 cells had 
been properly stimulated, we measured expression of the ac-
tivation markers CD44 and CD62L and CFSE dilution (Fig. 
1, B and C). 3 d after priming with OVA-pulsed DCs, all 
DO.11 cells showed increased CD44 and reduced CD62L 
levels and had lost the CFSE dye, whereas no CFSE dilution 
was observed when control DCs, which did not present 
OVA, were injected (Fig. 1, B and C). These data demon-
strated that the DO.11 cells had been activated and cycled 
strictly in response to antigen. 1 d after priming with DCs, 
a substantial fraction of the DO.11 T cells expressed IL-2Rα 
on the cell surface (Fig. 1 D). In contrast, expression of IL-
7Rα was lost early after priming. By day 3, IL-2Rα expres-
sion had decreased to the level of naive cells, whereas 
IL-7Rα was reexpressed. Furthermore, IL-7Rα was further 
up-  regulated by day 10. Thus, priming of DO.11 T cells 
in vitro and in vivo results in reciprocal expression of IL-2Rα 
and IL-7Rα, suggesting that regulation of receptor expres-
sion determines the temporal responsiveness of T cells to the 
respective cytokines.
IL-2–IL-2R𝗂 promotes the generation of activated T cells 
expressing IL-7R𝗂
We have previously shown that IL-2 signals are required for 
the generation of memory cells (17). Because expression of 
IL-7R appears to be a cardinal property of memory T cells, 
we postulated that one key function of IL-2 may be to pro-
mote sustained expression of the IL-7Rα chain. To address 
this possibility, IL-2−/− DO.11 T cells were primed in vitro 
in the absence or presence of recombinant IL-2. Under IL-2–
free priming conditions, the T cells show normal cell division 
and up-regulation of activation markers but fail to survive as 
well as WT T cells (17). Fig. 2 A demonstrates that IL-2−/− 
T cells lost IL-7Rα expression early after activation, inde-
pendent of the presence of IL-2 and similar to WT T cells. 
However, IL-2−/− T cells failed to reexpress IL-7Rα at 
the later stages of activation unless IL-2 was added back to the 
cultures. Thus, IL-2 is required during priming to induce the 
reexpression of IL-7Rα on late-activated T cells. Analysis of 
IL-7Rα mRNA by quantitative PCR confi  rmed the fl  ow 
cytometry data (unpublished data).
Next, we asked if IL-2 was also required for IL-7Rα ex-
pression during in vivo priming of T cells. Initially, we com-
pared IL-7Rα expression on WT and IL-2−/− DO.11 T cells 
primed in vivo with OVA-pulsed DCs and could not detect 
any diff  erences between these cell populations. However, it 
is possible that IL-2 produced by host T cells could compen-
sate for the lack of autocrine IL-2 production by the trans-
ferred IL-2−/− DO.11 T cells. Therefore, we analyzed 
IL-7Rα expression on DO.11 T cells defi  cient in CD25, the 
high affi   nity IL-2Rα. Because CD25−/− T cells are unable to 
respond to IL-2 present in the environment, they could be 
primed under exactly the same conditions as WT cells yet 
would be deprived of IL-2 signals. We found that CD25−/− 
T cells failed to restore IL-7Rα expression to the level of 
  naive or activated WT cells on day 4 after in vivo priming 
(Fig. 2 B). Thus, one of the functions of the IL-2–IL-2Rα 
system during the T cell response is to provide signals for the 
reexpression of IL-7Rα on late-activated T cells.
IL-7–IL-7R𝗂 is required for memory cell survival
IL-7 is an important survival factor for naive T cells (26). 
More recently, evidence has been presented that IL-7 is also 
important for the long-term survival of CD4+ memory T 
cells (20, 21). Therefore, reexpression of the IL-7Rα at the 
later stages of T cell activation could be necessary for the 
long-term survival of activated T cells once the antigen has 
been cleared. To formally test whether activated DO.11 T 
cells are dependent on IL-7 for their survival, we primed 
DO.11 T cells in vitro for 4 d and adoptively transferred 
30 × 106 activated T cells into unmanipulated BALB/c mice. 
Recipient mice were given either a blocking anti–IL-7Rα 
antibody or an isotype control antibody every other day 
for 10 d. The number of DO.11 cells surviving in lymph 
nodes and spleen was determined after 12 d. Treatment with 
Figure 2.  IL-2 regulates IL-7R𝗂 reexpression on activated T cells. 
(A) 2.5 ×105 IL-2−/− DO.11 T cells were primed in vitro with 1 μg/ml OVA 
peptide and 2.5 × 106 IL-2−/− APCs in the absence or presence of 10 ng/ml 
of added recombinant IL-2. IL-2Rα and IL-7Rα expression was exam-
ined as described in Fig. 1 A. Results are from one representative experi-
ment out of three. (B) 2 × 106 WT and CD25−/− DO.11 T cells were 
adoptively transferred into BALB/c recipients and primed in vivo with 106 
OVA-pulsed DCs. Histograms show IL-7Rα expression on KJ-26+CD4+ 
cells in the spleen. (bottom) Average mean fl  uorescence intensity (MFI) ± 
SD of IL-7Rα staining on WT and CD25−/− DO.11 T cells from the spleen 
(two mice per group). Primed WT and CD25−/− DO.11 T cells showed no 
difference in IL-7Rα expression on day 2 (P = 0.095), but signifi  cantly 
different IL-7Rα levels were measured on day 4 in both expt. 1 (P = 0.007) 
and expt. 2 (P = 0.0005).550  RECIPROCAL EXPRESSION OF IL-2 AND IL-7 RECEPTORS | Dooms et al.
anti–IL-7Rα reduced the number of DO.11 cells present in 
lymphoid tissues (Fig. 3 A). The recovered cells all showed 
a resting memory phenotype (Fig. 3 B). Total CD4+ T cell 
numbers were also reduced, confi  rming that IL-7 is required 
for naive T cell survival (unpublished data).
IL-2 during priming is required for both central 
and effector memory T cells
Our previous experiments demonstrating a role of IL-2 in the 
generation of memory CD4+ T cells have focused on mem-
ory cells in lymphoid organs (presumably corresponding to 
central memory cells) (17). To ask if the same requirement 
would be seen for memory cells in nonlymphoid peripheral 
tissues, we primed IL-2−/− DO.11 T cells in vitro for 4 d in 
the absence or presence of IL-2, adoptively transferred equal 
numbers of cells to BALB/c mice, and evaluated T cell sur-
vival in diff  erent organs 4 wk later. In agreement with previ-
ous fi  ndings (17), DO.11 cells primed in the absence of IL-2 
lacked the capacity to survive long-term in the secondary 
lymphoid organs (Fig. 4 A). We also found that IL-2−/− 
DO.11 cells failed to survive in nonlymphoid tissues such as 
the lung, whereas a population of DO.11 was recovered from 
this organ if the T cells had been primed in the presence of 
IL-2 (Fig. 4 A). This result shows that the absence of IL-2−/− 
memory cells in lymphoid organs is not caused by skewed 
homing of T cells to nonlymphoid organs or preferential de-
velopment of eff  ector memory cells, which are know to re-
side in nonlymphoid tissues.
It has been debated what the precise role of IL-2 is during 
CD4+ T cell responses and whether this cytokine is abso-
lutely required as a T cell growth factor in vivo (27). To 
evaluate the role of IL-2 during an in vivo T cell response, 
naive, CFSE-labeled CD25−/− DO.11 T cells were adop-
tively transferred into BALB/c mice and primed with OVA-
pulsed DCs. T cell numbers and cell division were followed 
over time in diff  erent organs. We have found that antigen-
presenting DCs do not survive in lymphoid organs beyond 
3 d after transfer, because freshly transferred DO.11 T cells 
cannot be primed after this time (28). Early evaluation of the 
spleen (day 2) revealed that equal numbers of DO.11 cells 
had settled there (Fig. 4 B), and no CFSE dilution had taken 
place by this time (not depicted). On day 4, WT and CD25−/− 
DO.11 T cells had expanded markedly in the spleen, and 
both had cycled equivalently (Fig. 4 C). Recovery of 
CD25−/− cells was signifi  cantly less than that of WT cells.
During an in vivo T cell response, the expansion phase 
is followed by deletion of the activated T cells to restore 
  homeostasis. By days 18–21,  60–90% of the primed T cells 
had been lost (Fig. 4 B). However, a signifi  cant population of 
WT DO.11 cells remained in the spleen and in nonlymphoid 
tissues, and these cells exhibited a memory phenotype (un-
published data). Approximately 50–60% fewer memory cells 
were recovered from hosts that had received CD25−/− 
DO.11 T cells, both in the spleen and in nonlymphoid tissues 
(lung and liver; Fig. 4 B). These data indicate that IL-2 is not 
required to drive primed T cells through initial replication 
but is required for initial survival and for the subsequent de-
velopment of a memory cell population.
IL-7R𝗂–reexpressing T cells show an enhanced capacity 
to survive as memory cells
From the previous experiments, it was not clear if the dimin-
ished recovery of memory cells from CD25−/− T cells was 
the consequence of defi  cient IL-7Rα reexpression or the 
  result of reduced clonal expansion in response to antigenic 
stimulation. To distinguish between these possibilities, we 
separated the expansion and memory phases of the response 
by priming WT and CD25−/− DO.11 T cells in a fi  rst recipi-
ent, harvesting the primed cells on day 3, and retransferring 
the recovered cells to a second recipient. Phenotypic analysis 
of the primed cells showed that at day 3 CD44 and CD62L 
were up- and down-regulated, respectively, similarly in acti-
vated WT and CD25−/− T cells, whereas CD25 was already 
mostly lost (Fig. 5 A). Confi  rming the data shown in Fig. 
2 B, primed CD25−/− cells showed  50% reduction in 
IL-7Rα expression level compared with WT cells or naive 
Figure 3.  IL-7–IL-7R𝗂 is required for CD4 memory cell survival. 
WT DO.11 T cells were primed in vitro as in Fig. 1 A. Primed cells were 
harvested on day 4, and 30 × 106 cells were adoptively transferred into 
BALB/c recipients. From day 2 after transfer, 1 mg anti–IL-7Rα or isotype 
control antibody was injected IP every other day for 10 d. Spleen and 
lymph nodes of the treated mice were harvested on day 12, and DO.11 
T cells were stained with KJ1-26 and anti-CD4 mAbs. (A) Absolute numbers 
of DO.11 T cells present in lymph nodes and spleen. Each symbol repre-
sents an individual mouse. Cell numbers with and without anti–IL-7Rα 
treatment were signifi  cantly different in both lymph nodes (P = 0.001) 
and spleen (P = 0.009). Horizontal lines represent mean cell numbers. 
(B) Expression of CD25, CD62L, and CD44 on DO.11 T cells from the spleen 
of one representative mouse treated with anti-IL-7Rα (bold line) or iso-
type control (continuous line).JEM VOL. 204, March 19, 2007  551
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CD25−/− cells (Fig. 5 B). The primed DO.11 WT and 
CD25−/− cells were subsequently purifi  ed from lymph nodes 
and spleen, equal numbers were transferred to new recipi-
ents, and survival followed. In all tissues examined (lymph 
nodes, spleen, and lung), CD25−/− cells survived poorly 
compared with WT cells, as predicted from reduced IL-7Rα 
expression (Fig. 5 C). Next, we asked whether the surviving 
CD25−/− T cells were bona fi  de memory cells. The surviv-
ing cells, whether WT or CD25−/−, all exhibited a resting, 
memory phenotype, with high CD44 and low CD62L (Fig. 
6 A). Interestingly, the surviving CD25−/− cells all expressed 
high levels of IL-7Rα, further suggesting that cells expressing 
high levels of IL-7Rα are preferentially retained. However, 
the recall responses of the surviving CD25−/− memory T 
cells, as measured by eff  ector cytokine production upon anti-
genic challenge, were markedly reduced when the T cells 
were primed in the absence of IL-2 signals (Fig. 6 B). Thus, 
it is possible that IL-2, analogous to what recently has been 
shown for CD8+ memory cells (29), is required for program-
ming secondary responses in CD4+ memory T cells.
Retrovirus-mediated expression of IL-7R𝗂 in IL-2−/− T cells 
restores memory cell survival
To formally demonstrate a causal relationship between 
  diminished IL-7Rα expression and the failure of primed 
  IL-2−/− T cells to generate a memory population, we re-
stored IL-7Rα expression in DO.11 IL-2−/− T cells and fol-
lowed the generation of memory cells. To do this, a bicistronic 
retroviral vector, containing an IL-7Rα cDNA and Thy1.1 
reporter gene, was introduced into IL-2−/− DO.11 T cells 
during in vitro priming, resulting in enhanced expression of 
IL-7Rα in the Thy1.1+ cell population (Fig. 7 A). 3 × 106 
Figure 4.  IL-2 during priming enhances T cell survival in vivo in 
lymphoid and nonlymphoid tissues. (A) IL-2−/− DO.11 T cells were 
primed in vitro with or without IL-2, as described in Fig. 2 A, and 10 × 106 
primed cells were adoptively transferred to BALB/c recipients. 4 wk later, 
DO.11 T cell numbers in the lymph nodes, spleen (P = 0.02), and lung (P = 
0.0009) of recipient mice were examined as in Fig. 3 A. Data points repre-
sent individual mice. (B) 2 × 106 (expt. 1) or 7.5 × 105 (expt. 2) CFSE-
labeled naive WT and CD25−/− DO.11 T cells were primed in vivo with 106 
(expt. 1) or 3 × 106 (expt. 2) OVA-pulsed DCs, and numbers of KJ1-26+CD4+ 
cells in the spleen, lung, and liver were determined. The two top panels 
show WT and CD25−/− DO.11 T cell numbers recovered from the spleens 
on days 2, 4, and 18–21. Cell numbers did not differ between both groups 
on day 2 (P = 0.07), but were signifi  cantly different on day 4 (expt. 1, 
P = 0.046; expt. 2, P= 0.023), day 18 (P = 0.029), and day 21 (P = 0.009). 
Bottom panels show DO.11 T cell numbers present in the lung and liver on 
day 18 (expt. 1) and day 21 (expt. 2). (C) CFSE dilution of WT and CD25−/− 
DO.11 cells in the spleen on day 4 after priming. Data shown are from one 
representative experiment (two mice per group) out of three.552  RECIPROCAL EXPRESSION OF IL-2 AND IL-7 RECEPTORS | Dooms et al.
IL-2−/− DO.11 T cells, transduced with either a control vec-
tor (48% of transferred cells being Thy1.1+) or an IL-7Rα–
containing vector (24% Thy1.1+), were adoptively transferred 
into BALB/c recipients, and the number of DO.11 cells pos-
itive for Thy1.1 was determined 3 wk later. DO.11 IL-2−/− 
cells that were transduced with IL-7Rα survived markedly 
better than cells that received the control vector (Fig. 7 B). 
The diff  erence was even more striking after normalizing cell 
numbers to equal input cell numbers (Fig. 7 C). In an addi-
tional experiment, Thy1.1+ IL-2−/− DO.11 T cells were pu-
rifi  ed from the transfection cultures by cell sorting, and equal 
numbers of cells expressing IL-7Rα or control vector were 
transferred into BALB/c recipients. 2 wk later, markedly 
higher numbers of DO.11 T cells were present in the lymph 
nodes and spleen of recipients that received cells expressing 
IL-7Rα versus control vector (Fig. 7, D and E). Transfer of 
sorted DO.11 T cells resulted in lower cell recoveries 
than transfer of unsorted cells (Fig. 7, C and E), perhaps 
  because of the loss of antibody-coated cells. Thus, these 
data demonstrate that overexpression of IL-7Rα in IL-2−/− 
cells is suffi     cient to restore their capacity for long-term 
  survival by enhancing their competitiveness to receive IL-7 
survival signals.
D  I  S  C  U  S  S  I  O  N 
The cytokines IL-2 and IL-7 both use the γc for transducing 
survival- and growth-promoting signals in T cells. Specifi  city 
of the response to IL-2 and IL-7 is assured by integrating a 
cytokine-specifi  c high affi   nity receptor chain in the receptor 
complex, the IL-2Rα or IL-7Rα, respectively. In this paper, 
we demonstrate that the expression of IL-2Rα and IL-7Rα 
is reciprocally regulated during a T cell response to antigen. 
This expression pattern provides a mechanism for the cell to 
respond to each cytokine at the appropriate time during the 
response, avoiding competition between the cytokines for γc 
usage. Naive T cells, which are dependent on IL-7 for their 
survival (26), express IL-7Rα on the cell surface. Because 
naive T cells do not produce IL-2, they cannot use IL-2 as an 
autocrine survival factor and, predictably, they do not express 
high levels of IL-2Rα. Upon TCR stimulation, IL-7Rα is 
down-regulated, whereas IL-2Rα expression is induced. 
TCR stimulation also induces production of IL-2, which T 
cells use in an autocrine fashion for clonal expansion and dif-
ferentiation. Furthermore, the decline of IL-7Rα expression 
means that the T cells cannot be maintained by the constitu-
tively produced survival cytokine, IL-7, and become depen-
dent on the newly secreted growth factor, IL-2. Such a 
pattern of receptor expression would promote preferential 
clonal expansion of the antigen-stimulated (and, therefore, 
antigen-specifi  c) T cells, the goal of the adaptive immune 
Figure 5.  Failure to reexpress IL-7R𝗂 in the absence of IL-2 
  correlates with reduced memory cell survival. 2 × 106 naive WT and 
CD25−/− T cells were adoptively transferred to BALB/c mice and primed in 
vivo with 3 × 106 OVA-pulsed DCs. Lymph nodes and spleen of recipient 
mice were harvested on day 3. (A) Naive (continuous line) and primed 
(bold line) KJ1-26+CD4+ T cells were stained for the activation markers 
CD44, CD62L, and CD25 and analyzed by fl  ow cytometry. Histograms 
represent pooled cell samples from recipients of WT (n = 10) and 
CD25−/− (n = 20) T cells. Data are representative of three separate exper-
iments. (B) Histograms compare IL-7Rα expression on naive (continuous 
line) with primed (bold line) WT and CD25−/− DO.11 T cells. MFI is indi-
cated. Dot plots compare IL-7Rα expression on KJ1-26+ with KJ1-26− 
cells from the CD4+ T cell population. Numbers refer to percentages of 
IL-7Rαlow vs. IL-7Rαhigh cells within the CD4+ population. Histograms and 
dot plots represent pooled cell samples from recipients of WT (n = 10) 
and CD25−/− (n = 20) T cells. One representative experiment out of three 
is shown. (C) CD4+ T cells were purifi  ed from the lymph nodes and 
spleens 3 d after priming, and 10 × 106 primed WT and CD25−/− DO.11 T 
cells were adoptively transferred to secondary BALB/c recipients. DO.11 
memory cell numbers in the lymph nodes (P = 0.02), spleen, and lung 
(P = 0.03) were analyzed as described for Fig. 4 B. Data points represent 
individual mice from one representative experiment out of two. Horizontal 
lines represent mean cell numbers.JEM VOL. 204, March 19, 2007  553
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  response. At the end of the acute phase of the response, IL-2 
production ceases, IL-2Rα expression wanes, and IL-7Rα is 
reexpressed. Because it has recently been demonstrated that 
IL-7 is required for the survival of CD4+ memory T cells, it 
can be postulated that activated T cells reexpressing IL-7Rα 
will preferentially enter the memory T cell pool. Similarly, it 
has been demonstrated that the subpopulation of CD8+ ef-
fector T cells expressing IL-7Rα at the peak of an antiviral 
response was most likely to develop into long-lived memory 
cells (30). Our data suggest that, also for CD4+ T cells, high 
levels of IL-7Rα at the peak of the response predict enhanced 
potential for memory cell generation (Figs. 4 B and 5 C). 
Importantly, high IL-7Rα expression, although required, 
was not the sole determinant of memory cell generation, be-
cause the majority of primed, IL-7Rαhigh cells still died mas-
sively (8 × 106 on day 4 vs. 6 × 105 on day 18 in the spleen; 
Fig. 4 B). Thus, either a subset of committed memory cells 
exists within the IL-7Rαhigh primed CD4+ T cells, or the 
ensuing memory cell population has, in a stochastic manner, 
escaped deletion mechanisms operating during the contrac-
tion phase of the response.
Because the IL-7–IL-7Rα system is essential for CD4+ 
and CD8+ memory T cell homeostasis, it is important to 
identify the factors that regulate IL-7Rα expression during a 
T cell response. Based on our previous data showing that IL-2 
is needed for memory responses, as well as the results of a 
  microarray study cataloging IL-2–dependent gene expression 
in primed T cells (unpublished data), we hypothesized that 
IL-2 was required for IL-7Rα expression on primed T cells. 
We found that DO.11 T cells primed with antigen and APCs 
in vitro and in vivo in the absence of IL-2 signals failed to re-
express IL-7Rα with the same kinetics as WT cells after ini-
tial TCR-triggered down-regulation of the receptor (Fig. 2). 
IL-7Rα reexpression was more dramatically dependent on 
IL-2 in T cells primed in vitro than in vivo, suggesting that 
additional factors controlling IL-7Rα expression may be pre-
sent in vivo. IL-15, sharing the IL-2/15Rβ for signaling with 
IL-2, is a possible candidate for this function. Our results 
contrast with those from an earlier report indicating that IL-2 
negatively regulates IL-7Rα expression on activated T cells 
(25). However, whereas we used a physiologically relevant T 
cell priming system with antigen and APCs in vitro and, 
more importantly, during an in vivo T cell response, these 
authors relied on in vitro stimulation with anti-CD3 and 
anti-CD28 antibodies. It is possible that continuous TCR 
engagement by the immobilized antibodies may lead to per-
sistent down-regulation of IL-7Rα.
We have previously shown that T cells primed with IL-2 
acquire a competitive survival advantage over cells primed in 
the absence of IL-2 (17). Thus, IL-2−/− DO.11 cells primed 
in vitro and subsequently adoptively transferred to BALB/c 
mice survived poorly in comparison with WT DO.11 cells. 
However, primed IL-2−/− DO.11 T cells persisted effi   ciently 
after adoptive transfer into lymphopenic Rag−/− mice, where 
competition with other lymphocytes was absent (17). The 
diff  erential long-term survival capacity of primed IL-2−/− 
Figure 6.  Phenotypic and functional properties of memory cells 
generated in the absence of IL-2. 106 WT and CD25−/− DO.11 T cells 
were primed in vivo with 3 × 106 OVA-pulsed DCs and analyzed 4 wk 
later. (A) Histograms show the phenotype of the WT (open) and CD25−/− 
(shaded) memory T cells recovered from the spleen. One representative 
mouse out of three is shown. (B) Some recipients were rechallenged with 
3 × 106 OVA-pulsed DCs, and 3 d later splenocytes were stained for cyto-
kine production after brief in vitro restimulation. Dot plots show the fre-
quency of IL-2–, IFN-γ–, and IL-4–producing cells within the CD4+ 
KJ1-26+ population. The bar graph shows total numbers of cytokine-
producing DO.11 T cells. Error bars display SD (n = 3).554  RECIPROCAL EXPRESSION OF IL-2 AND IL-7 RECEPTORS | Dooms et al.
T cells in intact versus lymphopenic mice can be explained 
by defi  cient IL-7Rα expression: CD4+ memory T cells are 
dependent on IL-7 to persist in intact hosts (20, 21), whereas 
survival and homeostatic proliferation of memory CD4+ T 
cells in lymphopenic animals is IL-7 independent (31). Now 
we also show that if DO.11 T cells are unable to receive IL-2 
signals caused by deletion of the IL-2Rα gene, the cells de-
velop poorly into long-lived memory cells after priming with 
antigen and APCs in vivo.
There has been ongoing discussion about the role of IL-2 
in T cell responses. Although initially described as the proto-
typic T cell growth factor (32), analysis of mice defi  cient in 
IL-2 or IL-2Rα/β surprisingly showed a lymphoproliferative 
phenotype leading to autoimmune disease (33–35). This gen-
erated considerable interest in the function of IL-2 as a nega-
tive regulator of the immune system. The dependence of T 
regulatory cells on IL-2 for development and maintenance 
(36–39) and the capacity of IL-2 to sensitize repeatedly stim-
ulated T cells for cell death by activating the Fas/FasL death 
pathway (40–42) have both been proposed as explanations 
for the negative regulatory role of IL-2. On the other hand, 
priming of IL-2−/− (43) or CD25−/− (44) T cells in vivo 
showed only a limited impact of IL-2 defi  ciency on initial T 
cell clonal expansion. These studies have raised uncertainties 
about the obligatory role of IL-2 as a T cell growth factor 
in vivo. By using CD25−/− T cells to exclude the eff  ects of 
  bystander IL-2, priming with antigen and APCs, and separating 
the acute and memory phases of the T cell response, we have 
Figure 7.  Retrovirus-mediated expression of IL-7R𝗂 in IL-2−/− 
T cells restores memory cell generation. (A) IL-2−/− DO.11 T cells were 
retrovirally transduced with IL-7Rα or empty vector, and IL-7Rα and 
Thy1.1 expression were evaluated on day 4 by antibody staining and fl  ow 
cytometry. MFI of IL-7Rα staining on the gated (Thy1.1+) population is 
indicated. (B) 3 × 106 IL-2−/− DO.11 T cells, of which 48% (empty vector) 
and 24% (IL-7Rα) expressed the Thy1.1 reporter gene, were adoptively 
transferred to BALB/c recipients, and the presence of Thy1.1+ DO.11 T cells 
was analyzed 3 wk after transfer. (right) Dot plots show the percentage of 
KJ1-26+Thy1.1+ cells within the CD4+ population in the spleen of one 
representative recipient. (C) To normalize for the difference in the num-
ber of Thy1.1+ cells transferred between both groups, the number of 
KJ1-26+Thy1.1+ memory cells recovered from the lymph nodes and spleen 
per 106 KJ1-26+Thy1.1+ cells transferred was calculated. Data points repre-
sent individual mice. (D) IL-2−/− DO.11 T cells were retrovirally transduced 
as in A, and Thy1.1+KJ1-26+CD4+ cells were purifi  ed from the cultures on 
day 4 by cell sorting. 2 × 106 Thy1.1+KJ1-26+CD4+ cells expressing either 
IL-7Rα or control vector were adoptively transferred into BALB/c recipi-
ents, and the presence of Thy1.1+ DO.11 T cells was analyzed 2 wk after 
transfer. Dot plots show the percentage of KJ1-26+Thy1.1+ cells within 
the CD4+ population in the spleen of one representative recipient. (E) 
Total number of KJ1-26+Thy1.1+CD4+ cells recovered from the lymph 
nodes and spleen per 2 × 106 purifi  ed cells transferred. Data points rep-
resent individual mice.JEM VOL. 204, March 19, 2007  555
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further elucidated the role of IL-2 during an in vivo CD4+ T 
cell response. Our data demonstrate in a defi  nitive way that 
IL-2 signals during priming are not required for initial cell 
proliferation but are more important to endow primed T 
cells with long-term survival potential once the antigen has 
been cleared. Confi  rming our previous studies with in vitro 
primed IL-2−/− T cells (17), IL-2 is not required to drive T 
cells through the cell cycle in vivo (Fig. 4 C). Although 
CD25−/− T cells expanded considerably after antigenic stimu-
lation, we generally recovered less primed CD25−/− T cells 
than WT cells at days 3–4, in accordance with another study (44). 
Whether this diminished clonal expansion of primed T cells 
is a direct eff  ect of the lack of IL-2 growth factor activity or 
is caused by a failure to receive IL-7 signals remains an open 
question. However, the most striking consequence of IL-2 
deprivation during priming is the subsequent diminished 
  capacity to generate a memory T cell population. This defect 
is likely caused by failed reexpression of IL-7Rα on late-
activated T cells, because we (Fig. 3) and others have shown 
that survival of CD4+ memory T cells is dependent on IL-
7Rα (19–21) and that ectopic expression of IL-7Rα in 
primed IL-2−/− T cells restores memory cell generation (Fig. 7). 
Identifi   cation of the IL-2–induced signaling pathway that 
leads to IL-7Rα reexpression will be an important goal of 
future research. Also of interest is to investigate whether GA 
binding protein, a transcription factor recently implicated in 
IL-7Rα expression in T cells, is induced by IL-2 (45).
Finally, these results demonstrate that optimal generation 
of memory T cell responses will require strategies for maxi-
mizing the expression of IL-7Rα on primed cells. It is also 
likely that analyzing IL-7Rα expression on antigen-specifi  c 
T cells after vaccination may predict the effi   cacy of the vac-
cine. Such prospective studies may help improve the success 
of prophylactic vaccination, based on experimental results.
MATERIALS AND METHODS
Mice. BALB/c mice were purchased from Charles River Laboratories and 
used as recipients for adoptive transfer experiments at 6–8 wk of age. 
DO.11.10 transgenic mice, expressing a TCR specifi  c for the hen egg albu-
min peptide OVA323-339 presented by MHC class II molecule I-Ad, were a 
gift from K. Murphy (Washington University, St. Louis, MO). DO.11.10 × 
IL-2−/− mice were generated in our laboratory by crossing DO.11.10 mice 
with IL-2−/− mice (backcrossed for >10 generations onto the BALB/c 
background; The Jackson Laboratory). Generation of DO.11.10 × CD25−/− 
mice has been previously described (46). Transgenic mice were genotyped 
using PCR and fl  ow cytometry. All mice were bred and maintained in ac-
cordance with the guidelines of the Laboratory Animal Resource Center of 
the University of California, San Francisco.
Antibodies, CFSE labeling, and fl  ow cytometry. DO.11.10 T cells 
were detected by staining with allophycocyanin- or PE-conjugated KJ1-26 
TCR clonotypic antibody, generated in our lab from the hybridoma cell line 
(a gift from P. Marrack, National Jewish Research and Medical Center, 
Denver, CO), and peridinin chlorophyllprotein–conjugated anti-CD4 mAb 
after blocking Fc receptors with anti-CD16/CD32 (both purchased from 
BD Biosciences). The following antibodies coupled to the indicated fl  uoro-
chromes were used for detection of activation markers and cytokine recep-
tors: anti-CD44–PE (IM7), anti-CD62L–PE or –FITC (MEL-14/L-selectin), 
anti-CD25–allophycocyanin or –FITC (PC61/IL-2Rα; all obtained from 
BD Biosciences), and anti-CD127–biotin/streptavidin–PE (A7R34/IL-
7Rα; Chemicon International). Fluorescence intensities were measured 
with a fl  ow cytometer (FACSCalibur; Becton Dickinson), and data were 
analyzed with CellQuest software (Becton Dickinson). For in vivo blocking 
experiments, mAbs specifi  c for IL-7Rα (clone A7R34) produced by the 
  hybridoma cell line were purifi  ed with Protein G Sepharose 4 Fast Flow (GE 
Healthcare). Rat IgG (Jackson ImmunoResearch Laboratories) was used as a 
control. To follow cell division during priming, naive CD4+ T cells were 
labeled with 1 μM CFSE (Invitrogen) for 10 min at room temperature in 
serum-free medium. Excess CFSE was quenched with 50% FCS, followed 
by three washes with PBS. On days 3–4 after adoptive transfer and priming, 
spleens from the recipient mice were harvested, and CFSE content of KJ1- 
26+CD4+ cells was determined by fl  ow cytometry. For intracellular cyto-
kine staining, splenocytes were restimulated ex vivo for 4 h with 1 μg/ml 
OVA peptide in the presence of 10 μg/ml BrefeldinA (Epicentre Biotech-
nologies) for the last 3 h and stained with anti–IL-2, anti–IL-4, and anti–
IFN-γ antibodies (BD Biosciences) using a Cytofi   x/Cytoperm Kit (BD 
Biosciences), according to the manufacturer’s instructions.
T cell priming and adoptive transfers. In vitro T cell priming and adop-
tive transfer of WT and IL-2−/− DO.11 T cells were performed as previ-
ously described (17). In brief, 2.5–5 × 105 CD4+ T cells from WT and 
IL-2−/− DO.11 mice were primed with 2.5 × 106 mitomycin C–treated 
BALB/c splenocytes and 1 μg/ml OVA323-339 in 24-well plates for 4–5 d. 
IL-2−/− splenocytes were used for cultures with IL-2−/− DO.11 cells to 
avoid the eff  ects of bystander IL-2. In some experiments, 10 ng/ml recom-
binant mIL-2 (R&D Systems) was added to the cultures. Primed T cells 
were harvested on day 4, and dead cells were removed by centrifugation 
over a density gradient (Lympholyte-M; Cedarlane Laboratories). Equal 
numbers of viable KJ1-26+CD4+ T cells were adoptively transferred into 
unmanipulated BALB/c mice by tail vein injection. For in vivo priming, 
1–5 × 106 naive WT or CD25−/− DO.11 T cells were adoptively transferred 
to sex-matched BALB/c mice and primed the next day with 1–3 × 106 ma-
ture bone marrow–derived DCs. DCs were generated by culturing 5–10 × 106 
bone marrow cells in 100-mm suspension culture dishes (Corning) for 
8–11 d with 20 ng/ml GM-CSF in Iscove’s modifi  ed Dulbecco’s medium 
(Sigma-Aldrich) supplemented with 1 mM l-glutamine, penicillin, strepto-
mycin (all obtained from Life Technologies), 5 × 10−5 M 2-ME, and 10% 
fetal bovine serum (Sigma-Aldrich). On days 5 and 8, nonadherent and 
loosely adherent cells were harvested by treatment with 3 mM EDTA in 
PBS and transferred to new plates. 1 ng/ml IL-4 was added for the last 3 d 
of culture. DCs were matured with 1 μg/ml LPS (Escherichia coli O26:B6; 
Sigma-Aldrich) and pulsed with 1 μg/ml OVA peptide 24 h before injec-
tion. For the experiments described in Fig. 5, lymph nodes and spleen were 
harvested on days 3–4 after in vivo priming, and CD4+ T cells were 
magnetically purifi  ed with anti–mouse CD4-coated Dynabeads, according 
to the instructions of the manufacturer (Dynal). Equal numbers of viable 
KJ1-26+CD4+ T cells were transferred to a second set of BALB/c recipients 
by tail vein injection.
Analysis of memory cells in lymphoid and nonlymphoid tissues. 
DO.11 memory T cells in spleen, pooled peripheral lymph nodes (subman-
dibular, axillary, brachial, inguinal, and popliteal), liver, and lung were quan-
tifi  ed 2–4 wk after priming. To recover lymphocytes from nonlymphoid 
tissues, mice were perfused with PBS, and lungs and liver were excised. 
Lung and liver tissue was mechanically dissociated and treated with 400 U/ml 
and 100 U/ml, respectively, collagenase VIII (C2139; Sigma-Aldrich) for 
30 min at 37°C, regularly pipetting the suspension up and down. The result-
ing suspension was passed through a 70-μM nylon screen, and lymphocytes 
were isolated by density gradient centrifugation using Lympholyte-M. The 
percentage of KJ1-26+CD4+ memory T cells in the cell suspensions was de-
termined by fl  ow cytometry. Absolute numbers of DO.11 T cells in lymph 
nodes and spleen were calculated from this percentage and counts of total 
cell numbers in a hemocytometer (Improved Neubauer; Reichert) using 
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T cells were evaluated by rechallenging previously primed recipients of WT 
and CD25−/− DO.11 T cells with 3 × 106 OVA-pulsed DCs and staining 
splenocytes for cytokine production 3 d later using intracellular cytokine 
staining and fl  ow cytometry.
Cloning and retrovirus-mediated transfection of IL-7R𝗂. A full-
length cDNA clone of the mouse IL-7Rα (clone 6758487; I.M.A.G.E. 
Consortium) (47) was obtained from Open Biosystems. The IL-7Rα coding 
sequence was isolated by restriction digest with the enzyme BsrG I (New 
England Biolabs, Inc.) and ligated into the BsrG I site of the retroviral vector 
MSCV 1.1 containing an IRES-Thy1.1 reporter gene (a gift from W. Sha, 
University of California, Berkeley, Berkeley, CA). Retroviral transfections 
of DO.11 T cells were performed as previously described (48). Cultures of 
retrovirally infected cells were harvested on day 4, and the percentage of 
transfected cells was determined by staining with an anti-Thy1.1 antibody 
(BD Biosciences) and fl  ow cytometry before adoptive transfer to BALB/c 
recipients. In one experiment, Thy1.1+KJ1-26+CD4+ cells were sorted 
(>98% purity) from the transfection cultures with a cell sorter (MoFlo; 
DakoCytomation) before adoptive transfer.
Statistics. The statistical signifi  cance of diff  erences between groups was de-
termined using the two-tailed Student’s t test.
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